Shanghai Fosun Med-Tech Development Co.,Ltd. (Shanghai Fosun) is a China based private company engaged in producuing in vitro diagnostic(IVD) products. The company offeres product portfolio consist of four product lines such as clinical chemistry reagents, microbiology, molecular diagnostic products, and immunoassays. Shanghai Fosun offers a wide range of products including liquid reagents, dry powder reagents, auto biochemistry system under clinical chemistry. Real-time PCR reagents, real-time PCR system are offered through molecular diagnostics. Moreover, it delivers biologs multi-trait, format—metabolic, one basice testing protocol, identification system, and susceptibility testing under microbiology. In addition to all the above, Shanghai Fosun also delivers enzyme immunoassay, special protein, T-SPOT and HIV. The company is operating four GMP facilities for IVD Products. National Enterprise Technology Center and Post-Doctor program. Shanghai Fosun is awarded by National Standardization Administration of Medical Laboratory and In Vitro Clinical Laboratory Diagnostics System in 2009. It is a division of Shanghai Fosun Pharmaceutics (Group) Co. Ltd. The company is headquartered in Shanghai, China.
This comprehensive SWOT profile of Shanghai Fosun Medical Technology Development Co., Ltd. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the 'Profile on Demand' Service, covering over 50,000 of the world's leading companies. Once purchased, We will comprehensively research and author a full strategic analysis of Shanghai Fosun Medical Technology Development Co., Ltd. and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Introduction
GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psoriasis. It includes an overview of the tri ... more
Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also involved in providing various health care services. The company through its wholly owned subsidiary, Ceres Living, produces and sells the AI ... more
Introduction
GlobalData’s new report, “Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Austria Neurology Devices market. The report provides value (USD mill ... more
Drugs under development to treat those affected by acute spinal cord injuries are not expected to emerge within the current decade, leaving the market largely open to new entrants, according to a new report issued by pharmaceuticals intelligence provider GlobalData.The new report, "Acute Sp ... more
Rare and niche diseases are being increasingly spotlighted by pharmaceutical and biotechnology corporations in the hope of developing initial treatments or improving upon existing therapies for these conditions, according to a new report released by GlobalData.The new report, "Rare and Nich ... more
Arguably, two of the most noteworthy advancements in medicine and technology in the last decade have been genomics research and cloud computing, according to GlobalData. These two advancements have been on separate pathways, each having little to do with the other - until now. Today, medica ... more